APRI

Apricus Biosciences Receives FDA Clearance to Begin Clinical Trial of RayVa(TM) for Secondary Raynaud’s Phenomenon

[GlobeNewswire] – SAN DIEGO — Apricus Biosciences, Inc. , a pharmaceutical company focusing on the development and commercialization of novel therapeutics for men’s and women’s health, today announced that the U.S. Food … moreView todays social media effects on APRIView the latest stocks trending across Twitter. Click to view dashboardSee who Apricus is hiring next, click here to view […]

Apricus Biosciences’ CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Rich Pascoe Thank you, Angeli and good afternoon and thank you all for joining us on the call today. Throughout 2013, we have made significant strides towards focusing and strengthening the company in … moreView todays social media effects on APRIView the latest stocks trending across Twitter. Click to view dashboardSee who Apricus is hiring next, […]

Apricus Shares Marginally Down on Vitaros Deal

moreView todays social media effects on APRIView the latest stocks trending across Twitter. Click to view dashboardSee who Apricus is hiring next, click here to view […]